Given the costs typically associated with injectable weight-management therapies and existing NHS prescribing frameworks, access if approved may initially be limited to specific patient groups meeting defined clinical criteria, as has been the case with other agents in this class
The Beagle Study The other piece of evidence is more direct
Compounded GLP-1 microdose medications are only indicated when a prescribing practitioner determines they offer a significant difference from the FDA-approved product, as compounded medications are not reviewed by the FDA for safety, efficacy, or quality
Horvth, O., Valicsek, Z., Harrach, G., Lendvay, G
It would also be valuable to explore whether dual-site stimulation, combining the subcortical and cortical SCAN stimulation, could provide further benefits compared with DBS